Evidence map›Paper›PMID 35695324›Full record

ArticleESC heart failure2022

Utilizing longitudinal data in assessing all-cause mortality in patients hospitalized with heart failure.

Robert Herman, Marc Vanderheyden, Boris Vavrik, Monika Beles, Timotej Palus, Olivier Nelis, Marc Goethals, Sofie Verstreken, Riet Dierckx, Martin Penicka and 2 more

Abstract read
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Robert HermanPowerful Medical, Bratislava, Slovak Republic.ORCID 0000-0002-8773-1732
Marc VanderheydenCardiovascular Center, OLV Hospital, Aalst, Belgium.
Boris VavrikPowerful Medical, Bratislava, Slovak Republic.
Monika BelesCardiovascular Center, OLV Hospital, Aalst, Belgium.
Timotej PalusPowerful Medical, Bratislava, Slovak Republic.
Olivier NelisCardiovascular Center, OLV Hospital, Aalst, Belgium.
Marc GoethalsCardiovascular Center, OLV Hospital, Aalst, Belgium.
Sofie VerstrekenCardiovascular Center, OLV Hospital, Aalst, Belgium.
Riet DierckxCardiovascular Center, OLV Hospital, Aalst, Belgium.
Martin PenickaCardiovascular Center, OLV Hospital, Aalst, Belgium.
Ward HeggermontCardiovascular Center, OLV Hospital, Aalst, Belgium.
Jozef BartunekCardiovascular Center, OLV Hospital, Aalst, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsRisk stratification in patients with a new onset or worsened heart failure (HF) is essential for clinical decision making. We have utilized a novel approach to enrich patient level prognostication using longitudinally gathered data to develop ML-based algorithms predicting all-cause 30, 90, 180, 360, and 720 day mortality. METHODS AND

resultsIn a cohort of 2449 HF patients hospitalized between 1 January 2011 and 31 December 2017, we utilized 422 parameters derived from 151 451 patient exams. They included clinical phenotyping, ECG, laboratory, echocardiography, catheterization data or percutaneous and surgical interventions reflecting the standard of care as captured in individual electronic records. The development of predictive models consisted of 101 iterations of repeated random subsampling splits into balanced training and validation sets. ML models yielded area under the receiver operating characteristic curve (AUC-ROC) performance ranging from 0.83 to 0.89 on the outcome-balanced validation set in predicting all-cause mortality at aforementioned time-limits. The 1 year mortality prediction model recorded an AUC of 0.85. We observed stable model performance across all HF phenotypes: HFpEF 0.83 AUC, HFmrEF 0.85 AUC, and HFrEF 0.86 AUC, respectively. Model performance improved when utilizing data from more hospital contacts compared with only data collected at baseline.

conclusionsOur findings present a novel, patient-level, comprehensive ML-based algorithm for predicting all-cause mortality in new or worsened heart failure. Its robust performance across phenotypes throughout the longitudinal patient follow-up suggests its potential in point-of-care clinical risk stratification.

Indexed as

Heart FailureCohort StudiesHospitalizationHumansStroke VolumeTime FactorsBig data analysisHeart failureMachine learningMortality predictionPrecision medicineRisk stratification

Identifiers

PMID35695324
PMCPMC9715844

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.